A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis

Clinical trial NCT06745531 · COMPLETED

Trial details

NCT number: NCT06745531
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperphosphatemia Patients on Hemodialysis

Start date: 2025-01-06
Primary completion: 2025-10-13
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.